Although exposure to many industrially important monomers is controlled by law, few of these reactive chemicals have been determined in human tissues. Analogy with other fat-soluble organic substances strongly implies that these monomers may be retained in tissue, suhject to the usual physiological constraints of metabolism, solubility and volatility. The storage of DDT and PCBs is discussed, as well as tetrachloroethylene (PCE) and trichloroethylene (TCE), which are chemically similar to many industrially used monomers. Styrene in blood and breath and its metabolites in urine have been studied in humans. Styrene and vinyl chloride have been measured in fat tissue of polymerization workers.
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Evidence for the presence of monomers and other unmetabolized organic materials in humans is surprisingly scarce, in spite of exposures to a large number of substances in the environment that are very fat soluble, and therefore prime candidates for prolonged body residence.
Recent epidemiological and clinical field studies have been conducted by this laboratory among workers exposed to organic materials, including polymerization workers, anesthesiologists and workers making capacitors and transformers (PCB workers), and our interest has been directed toward the study of the storage and turnover in blood and adipose tissue of fat-soluble organic compounds.
The distributional dynamics of many such compounds in the body can be derived using the compartmental model, with which anesthesiologists have studied uptake and elimination of anesthetics. Thus (4, 5) .
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Demonstrated precedents for fat storage in humans are limited to pesticides and PCBs. DDT is perhaps the most extensively studied material in humans and animals and is a substance which defies all normal excretory attempts: it is nonvolatile, very lipid soluble and very difficult to metabolize. In the occupational setting, a relationship between exposure level and fat level of DDT has been observed, with 300-600 ppm found in adipose tissue of workers (6, 7). The health implications of DDT retention are not established, although Poland et al. demonstrated, among workers with high fat and blood DDT, an elevated, but not linearly correlated, enzymatic capacity for phenylbutazone (6) . In animals a threshold of DDT in fat (11 uLg/g) is necessary to affect phenobarbital metabolism rate (8) . An ingested dose of DDT is retained in human fat tissue for as long as 3 yr, while in corresponding animal tissues, elimination of similar levels was accomplished in 0.5-1.5 yr (9). Clearly, extrapolation from the animal to human situation is not straightforward.
PCBs are a similarly chemically inert organic family (contributing to their industrial utility), which have been detected in water, birds, fish, and human tissues. Severe cases of symptomatic PCB exposures occurred in Japanese persons who consumed contaminated rice oil (Yusho disease, Table 1 ). Levels of about 40 ppm PCB in fat tissue were observed initially in these persons, declining over a period of 2-5 yr to that of the general population in Japan (0.2-4 ppm) (10) . PCBs have been found at trace-2ppm levels (11) in the United States general population (Table 2 ). Blood levels of Japanese PCB workers were determined to be ca. 0.4 ppm (10 (16, 17) .
Vinyl chloride (VC) exposure has been associated with excess cancer incidence among vinyl chloride-exposed workers, and in animals (18) . In laboratory animals most of the VC absorbed during inhalation was metabolized.
Of a radiolabeled dose, only 0.02% was detected as expired monomer, with 98% of the dose recovered. A small amount of radioactivity was retained after 75 hr, mainly in the liver (19) .
VC has been detected in the subcutaneous fat of polymerization workers (Table 3 ). In spite of its volatility and its facile metabolism by rats, the lipophilicity of VC appears to allow fat retention in humans (20) . 
heavy (H) or light
Human uptake and metabolism of styrene has been fairly well studied. Styrene can be absorbed by inhalation or skin contact. During exposure to 20-100 ppm, about 60% of the styrene inhaled is absorbed by the body (3, 21) . Of this amount, metabolism to mandelic acid (85%c) and phenylglycolic acid (10%) accounts for most of the absorbed styrene (3). Metabolism to hippuric acid and conjugates of phenylglycol also occurs (17) . Exhalation accounts for about 1% of the styrene absorbed (22, 23) .
Styrene is very soluble in blood and fat, more so than many halogenated hydrocarbons. Following exposure at 100 ppm, blood levels of 0.2-15 ppm styrene have been determined (22, 23) . As with PCE and TCE, blood and breath levels are proportional to the intensity and not duration, of exposure. Persistence in breath is related to duration of exposure. Thus, after 2 and 7 hr exposure to 100 ppm styrene, breath levels decrease from 2-3 ppm to 0.05 and 0.5 ppm, respectively over a period of 6 hr (23). Exertion during exposure to styrene changes blood, but not breath, concentrations. During exposure to 150 ppm styrene, blood levels varied with exercise from 2 ppm (at rest), to 6 ppm (50-watt exercise), to 16 ppm (150-watt exercise) (22) .
The urinary half-life of styrene metabolites is about 8 hr, with detectable levels continuing for 30 hr (17) . (The breath half-life of styrene is 1-3 hr, with detectable levels persisting as long as 20 hr (ca. 0.1 ppm) (23). Blumberg, work in progress.).
October 1976
Fat levels of styrene were detected more than 48 hr following the last exposure, longer than detectability in breath of experimental subjects after sustained exposure at 100 ppm (23) . This finding is of interest, since styrene is a monomer more readily metabolized than the halogenated hydrocarbons.
Several recent studies suggest important areas for future investigations. Exposure to dichloromethane has recently been correlated to high carboxyhemoglobenemia (24) . The persistence of bromine in rat tissue for 24 hr following exposure to brominated fire retardants has been reported at this conference. The demonstration by Montesano of marked mutagenic assay activity by chloroprene (25) (greater than for vinyl chloride) should stimulate study of this monomer in human and animal tissue. Its nonchlorinated analog, butadiene, has a very rapid turnover in animal tissues following very high exposures, similar to that of styrene under the same conditions (26) .
Another important industrial monomer which has not been adequately studied is acrylamide, a potent mg/mi3). It has been neurotoxin (TLV 0.3 measured in urine of polymerization workers, although no published data exist (27) . Exposure of acrylamide, a solid (mp 850C) vinyl amide, can occur via dust inhalation or dermal contact. Up to 2% monomer can be retained in the polymer. Its cumulative neurotoxicity has a demonstrated threshold in animals, and the biological halflife in animals is 24 hr. Most of a radioactive dose in animals appears to be bound to blood and tissue protein, persisting in significant amounts for more than 14 days (27) . Table 5 summarizes some of the reported findings of industrial chemicals in blood and fat. Table 6 summarizes some available turnover data for fat-soluble industrial chemicals. Environmental Health Perspectives
